Value Microcaps Motherboard

[Knowledge is King]

Growth-stock PCHM($.75) P/E is <2, net of cash...

Pharmchem reported 2016 results on their website today, and declared another $.05/share dividend:


https://69232158b6ac9cf4fa7b-2b1af90ce01fe18d8b360f5b74719145.ssl.cf1.rackcdn.com/document-uploads/2016-Stockholder-Letter.pdf


Check out these annual trends 2012-2016:

Sales: $1.65M, $1.78M, $2.52M, $3.23M, $4.17M

Net income: $75K, $153K, $434K, $608K, $1.04M

Cash: $951K, $1.06M, $1.62M, $2.3M, $2.9M


With 5.85M shares out, PCHM has 12-month EPS of $.17, and $.50/share in cash



And these two items from the new shareholder letter bode well for the future, IMO:

Our growth in 2017 is expected to ease somewhat but still achieve a double digit increase in sales.

We continue to explore opportunities to present PharmChem, its franchise and strategic value to those companies that can benefit from acquiring us at the appropriate valuation.